FDA Clears Blood Test for Colorectal Cancer Screening

The FDA has approved SimpleScreen™ CRC, a new blood-based test by Freenome, for colorectal cancer screening in average-risk adults aged 45 and older. Commercialized by Abbott, this approval expands screening options, potentially reaching millions of Americans overdue for traditional screening methods. The test showed 81.1% sensitivity for detecting colorectal cancer.